These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11728389)

  • 1. Synthesis and pharmacological activity of a novel water-soluble hepatocyte-specific polymeric prodrug of prostaglandin E(1) using lactosylated poly(L-glutamic hydrazide) as a carrier.
    Akamatsu K; Yamasaki Y; Nishikawa M; Takakura Y; Hashida M
    Biochem Pharmacol; 2001 Dec; 62(11):1531-6. PubMed ID: 11728389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a hepatocyte-specific prostaglandin E(1) polymeric prodrug and its potential for preventing carbon tetrachloride-induced fulminant hepatitis in mice.
    Akamatsu K; Yamasaki Y; Nishikawa M; Takakura Y; Hashida M
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1242-9. PubMed ID: 10454500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of polymeric prodrugs of prostaglandin E(1) having galactose residue for hepatocyte targeting.
    Hashida M; Akamatsu K; Nishikawa M; Yamashita F; Takakura Y
    J Control Release; 1999 Nov; 62(1-2):253-62. PubMed ID: 10518658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of polymeric prodrugs of PGE1 for cell-specific hepatic targeting.
    Hashida M; Akamatsu K; Nishikawa M; Yamashita F; Yoshikawa H; Takakura Y
    Pharmazie; 2000 Mar; 55(3):202-5. PubMed ID: 10756541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific targeting of a lipophilic prodrug of iododeoxyuridine to parenchymal liver cells using lactosylated reconstituted high density lipoprotein particles.
    Bijsterbosch MK; van de Bilt H; van Berkel TJ
    Biochem Pharmacol; 1996 Jul; 52(1):113-21. PubMed ID: 8678894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of prostaglandin E1 to hepatocytes using galactosylated liposomes.
    Kawakami S; Munakata C; Fumoto S; Yamashita F; Hashida M
    J Drug Target; 2000; 8(3):137-42. PubMed ID: 10938523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery.
    Hirabayashi H; Nishikawa M; Takakura Y; Hashida M
    Pharm Res; 1996 Jun; 13(6):880-4. PubMed ID: 8792426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific targeting of the antiviral drug 5-iodo 2'-deoxyuridine to the parenchymal liver cell using lactosylated poly-L-lysine.
    Biessen EA; Beuting DM; Vietsch H; Bijsterbosch MK; Van Berkel TJ
    J Hepatol; 1994 Nov; 21(5):806-15. PubMed ID: 7890898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier-mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to parenchymal liver cells: a novel therapeutic approach for hepatitis B.
    de Vrueh RL; Rump ET; van De Bilt E; van Veghel R; Balzarini J; Biessen EA; van Berkel TJ; Bijsterbosch MK
    Antimicrob Agents Chemother; 2000 Mar; 44(3):477-83. PubMed ID: 10681306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of prostaglandin E(1) phosphate derivatives and their encapsulation in biodegradable nanoparticles.
    Takeda M; Maeda T; Ishihara T; Sakamoto H; Yuki K; Takasaki N; Nishimura F; Yamashita T; Tanaka K; Takenaga M; Igarashi R; Higaki M; Yamakawa N; Okamoto Y; Ogawa H; Otsuka M; Mizushima Y; Mizushima T
    Pharm Res; 2009 Jul; 26(7):1792-800. PubMed ID: 19415470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactosylated low density lipoprotein: a potential carrier for the site-specific delivery of drugs to Kupffer cells.
    Bijsterbosch MK; Ziere GJ; Van Berkel TJ
    Mol Pharmacol; 1989 Sep; 36(3):484-9. PubMed ID: 2550781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition characteristics of glycosylated poly(amino acids) as liver cell-specific drug carrier.
    Akamatsu K; Imai M; Yamasaki Y; Nishikawa M; Takakura Y; Hashida M
    J Drug Target; 1998; 6(3):229-39. PubMed ID: 9888309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of a lipophilic prodrug of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and its incorporation into a hepatocyte-specific lipidic carrier.
    de Vrueh RL; Rump ET; Sliedregt LA; Biessen EA; van Berkel TJ; Bijsterbosch MK
    Pharm Res; 1999 Aug; 16(8):1179-85. PubMed ID: 10468017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactosylated PLGA nanoparticles containing ϵ-polylysine for the sustained release and liver-targeted delivery of the negatively charged proteins.
    Zhou P; An T; Zhao C; Li Y; Li R; Yang R; Wang Y; Gao X
    Int J Pharm; 2015 Jan; 478(2):633-43. PubMed ID: 25510599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactosylated high density lipoprotein: a potential carrier for the site-specific delivery of drugs to parenchymal liver cells.
    Bijsterbosch MK; Van Berkel TJ
    Mol Pharmacol; 1992 Feb; 41(2):404-11. PubMed ID: 1311413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor microenvironment-labile polymer-doxorubicin conjugate thermogel combined with docetaxel for in situ synergistic chemotherapy of hepatoma.
    Zhang Y; Zhang J; Xu W; Xiao G; Ding J; Chen X
    Acta Biomater; 2018 Sep; 77():63-73. PubMed ID: 30006312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility study of aerosolized prostaglandin E1 microspheres as a noninvasive therapy for pulmonary arterial hypertension.
    Gupta V; Rawat A; Ahsan F
    J Pharm Sci; 2010 Apr; 99(4):1774-89. PubMed ID: 19894275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endosomal pH-activatable poly(ethylene oxide)-graft-doxorubicin prodrugs: synthesis, drug release, and biodistribution in tumor-bearing mice.
    Zhou L; Cheng R; Tao H; Ma S; Guo W; Meng F; Liu H; Liu Z; Zhong Z
    Biomacromolecules; 2011 May; 12(5):1460-7. PubMed ID: 21332185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives.
    Yabe Y; Nishikawa M; Tamada A; Takakura Y; Hashida M
    J Pharmacol Exp Ther; 1999 May; 289(2):1176-84. PubMed ID: 10215702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro skin penetration and pharmacodynamic evaluation of prostaglandin E1 ethyl ester, a vasoactive prodrug of prostaglandin E1, formulated into alcoholic hydrogels.
    Park HS; Yang SW; Choi SU; Choi HG; Yong CS; Choi YW; Lee J
    Pharmazie; 2006 Nov; 61(11):933-7. PubMed ID: 17152986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.